Daewoong - Asset Resilience Ratio

Latest as of September 2025: 1.85%

Daewoong (003090) has an Asset Resilience Ratio of 1.85% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Daewoong to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩57.18 Billion

≈ $38.75 Million USD Cash + Short-term Investments

Total Assets

₩3.10 Trillion

≈ $2.10 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Daewoong's Asset Resilience Ratio has changed over time. See 003090 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Daewoong's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Daewoong.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩57.18 Billion	1.85%
Total Liquid Assets	₩57.18 Billion	1.85%

Asset Resilience Insights

Limited Liquidity: Daewoong maintains only 1.85% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Daewoong Industry Peers by Asset Resilience Ratio

Compare Daewoong's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
SIMCERE PHARMAC. GRP LTD F:S2P	Drug Manufacturers - Specialty & Generic	0.44%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Daewoong (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Daewoong.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.67%	₩72.62 Billion ≈ $49.21 Million	₩2.72 Trillion ≈ $1.84 Billion	-1.80pp
2023-12-31	4.47%	₩105.48 Billion ≈ $71.48 Million	₩2.36 Trillion ≈ $1.60 Billion	-4.62pp
2022-12-31	9.09%	₩196.30 Billion ≈ $133.03 Million	₩2.16 Trillion ≈ $1.46 Billion	-4.52pp
2021-12-31	13.61%	₩263.22 Billion ≈ $178.38 Million	₩1.93 Trillion ≈ $1.31 Billion	+3.97pp
2020-12-31	9.64%	₩177.20 Billion ≈ $120.09 Million	₩1.84 Trillion ≈ $1.25 Billion	-2.08pp
2019-12-31	11.72%	₩195.58 Billion ≈ $132.54 Million	₩1.67 Trillion ≈ $1.13 Billion	+3.18pp
2018-12-31	8.54%	₩135.99 Billion ≈ $92.16 Million	₩1.59 Trillion ≈ $1.08 Billion	+0.09pp
2017-12-31	8.45%	₩130.86 Billion ≈ $88.68 Million	₩1.55 Trillion ≈ $1.05 Billion	-2.83pp
2016-12-31	11.28%	₩165.53 Billion ≈ $112.18 Million	₩1.47 Trillion ≈ $994.36 Million	-0.98pp
2015-12-31	12.26%	₩152.27 Billion ≈ $103.19 Million	₩1.24 Trillion ≈ $841.89 Million	-4.02pp
2014-12-31	16.28%	₩164.50 Billion ≈ $111.48 Million	₩1.01 Trillion ≈ $684.96 Million	+9.62pp
2013-12-31	6.65%	₩59.77 Billion ≈ $40.50 Million	₩898.47 Billion ≈ $608.88 Million	+4.71pp
2012-12-31	1.94%	₩9.89 Billion ≈ $6.70 Million	₩509.22 Billion ≈ $345.09 Million	-0.52pp
2011-12-31	2.46%	₩11.73 Billion ≈ $7.95 Million	₩476.95 Billion ≈ $323.23 Million	+0.44pp
2010-12-31	2.02%	₩15.53 Billion ≈ $10.53 Million	₩770.12 Billion ≈ $521.90 Million	-11.70pp
2009-12-31	13.72%	₩96.91 Billion ≈ $65.67 Million	₩706.44 Billion ≈ $478.74 Million	+8.10pp
2008-12-31	5.62%	₩38.40 Billion ≈ $26.03 Million	₩683.79 Billion ≈ $463.39 Million	+0.93pp
2007-12-31	4.69%	₩25.30 Billion ≈ $17.15 Million	₩539.93 Billion ≈ $365.91 Million	+0.49pp
2006-12-31	4.19%	₩18.97 Billion ≈ $12.85 Million	₩452.46 Billion ≈ $306.62 Million	-0.65pp
2005-12-31	4.84%	₩18.73 Billion ≈ $12.70 Million	₩387.05 Billion ≈ $262.30 Million	-1.52pp
2004-12-31	6.36%	₩21.58 Billion ≈ $14.62 Million	₩339.21 Billion ≈ $229.88 Million	+3.32pp
2003-12-31	3.04%	₩9.69 Billion ≈ $6.56 Million	₩318.37 Billion ≈ $215.76 Million	-3.88pp
2002-12-31	6.92%	₩22.03 Billion ≈ $14.93 Million	₩318.26 Billion ≈ $215.68 Million	-6.52pp
2001-12-31	13.44%	₩46.16 Billion ≈ $31.29 Million	₩343.38 Billion ≈ $232.70 Million	-2.22pp
2000-12-31	15.67%	₩53.29 Billion ≈ $36.12 Million	₩340.15 Billion ≈ $230.52 Million	--

pp = percentage points

About Daewoong

KO:003090 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$497.97 Million

₩734.81 Billion KRW

Market Cap Rank

#12411 Global

#369 in Korea

Share Price

₩17970.00

Change (1 day)

-3.96%

52-Week Range

₩16610.00 - ₩29350.00

All Time High

₩76921.40